PPL’s client got one product approval, which PPL has been helping since research to commercialisation phase as per this article.
There are similar products in the market “And they’re all blockbusters — Jardiance notched sales of $4.3 billion, Farxiga $3 billion and Invokana $563 million in 2021.”
TheracosBio seems small compared to other companies, so their sales won’t match other competitors but it shall help PPL get few millions of sales for API/FD next years as TheracosBio is hoping to launch the product by June 2023 .